We are live on
!
Find out more
SM
SG3 Management Portfolio holdings
AUM
$6.45K
1-Year Est. Return
61.81%
This Fund
S&P 500
This Quarter
Est. Return
+12.91%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$4.92B
AUM Growth
+$1.62B
(+49%)
Cap. Flow
+$1.41B
Cap. Flow
% of AUM
28.67%
Top 10 Holdings %
Top 10 Hldgs %
36.75%
Holding
1,419
New
468
Increased
176
Reduced
163
Closed
410
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$208M |
| 2 |
Amazon
AMZN
|
+$165M |
| 3 |
Advanced Micro Devices
AMD
|
+$86.9M |
| 4 |
XYZ
Block Inc
XYZ
|
+$33.2M |
| 5 |
Roku
ROKU
|
+$27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLRN
Acceleron Pharma
XLRN
|
+$10.3M |
| 2 |
Moderna
MRNA
|
+$9.79M |
| 3 |
JD.com
JD
|
+$6.14M |
| 4 |
AstraZeneca
AZN
|
+$5.27M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$4.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 8.5% |
| 2 | Technology | 4.33% |
| 3 | Communication Services | 2.49% |
| 4 | Healthcare | 1.87% |
| 5 | Financials | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
NerdWallet
NRDS
$632M
| $156K | ﹤0.01% |
+10,000
| New | +$196K |
|
852
CALL
Wolfspeed
WOLF
$1.04B
| $156K | ﹤0.01% |
+1,400
| New | +$156K |
|
853
Intel
INTC
$413B
| $155K | ﹤0.01% |
3,000
-3,400
| -53% | -$174K |
|
854
Cameco
CCJ
$36.8B
| $153K | ﹤0.01% |
7,000
+3,000
| +75% | +$72.6K |
|
|
TUP
855
DELISTED
Tupperware Brands Corporation
TUP
| $153K | ﹤0.01% |
+10,000
| New | +$186K |
|
856
Air Products & Chemicals
APD
$65.5B
| $152K | ﹤0.01% |
+500
| New | +$147K |
|
857
Magnite
MGNI
$2.83B
| $149K | ﹤0.01% |
+8,500
| New | +$192K |
|
858
Torrid Holdings
CURV
$274M
| $148K | ﹤0.01% |
+15,000
| New | +$223K |
|
859
CALL
Xeris Biopharma Holdings
XERS
$1.45B
| $147K | ﹤0.01% |
+50,000
| New | +$108K |
|
|
ICPT
860
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $147K | ﹤0.01% |
9,000
| – | – |
|
|
GBT
861
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $146K | ﹤0.01% |
+5,000
| New | +$155K |
|
862
Ally Financial
ALLY
$13.1B
| $143K | ﹤0.01% |
+3,000
| New | +$149K |
|
863
Clover Health Investments
CLOV
$2.23B
| $140K | ﹤0.01% |
+37,500
| New | +$230K |
|
864
Micron Technology
MU
$835B
| $140K | ﹤0.01% |
+1,500
| New | +$117K |
|
865
PUT
Bilibili
BILI
$7.75B
| $139K | ﹤0.01% |
3,000
| – | – |
|
866
Comstock Resources
CRK
$3.7B
| $138K | ﹤0.01% |
17,000
+1,000
| +6% | +$9.14K |
|
|
RDUS
867
CALL
DELISTED
Radius Health, Inc.
RDUS
| $138K | ﹤0.01% |
20,000
+5,000
| +33% | +$73.4K |
|
|
RDUS
868
PUT
DELISTED
Radius Health, Inc.
RDUS
| $138K | ﹤0.01% |
20,000
+5,000
| +33% | +$73.4K |
|
|
NUAN
869
DELISTED
Nuance Communications, Inc.
NUAN
| $138K | ﹤0.01% |
+2,500
| New | +$138K |
|
870
DraftKings
DKNG
$12.2B
| $137K | ﹤0.01% |
5,000
+3,000
| +150% | +$118K |
|
|
ODP
871
DELISTED
ODP
ODP
| $137K | ﹤0.01% |
3,500
| – | – |
|
872
AB InBev
BUD
$164B
| $136K | ﹤0.01% |
2,250
-750
| -25% | -$43.6K |
|
873
CALL
Omeros
OMER
$845M
| $134K | ﹤0.01% |
20,800
-60,000
| -74% | -$435K |
|
|
MAG
874
DELISTED
MAG Silver
MAG
| $133K | ﹤0.01% |
8,500
| – | – |
|
875
Invesco Mortgage Capital
IVR
$759M
| $132K | ﹤0.01% |
4,750
+1,000
| +27% | +$31K |
|
Similar funds
EAM
CAM
CCM
GPCM
MAM
BGCI
TPL
RC
SG3 Management's Q4 2021 Portfolio in Review
As of Q4 2021, SG3 Management held 1,419 positions worth $4.92B, up 49% from $3.3B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
SG3 Management deployed $1.41B of net new capital in Q4 2021, opening 468 new positions and adding to 176 existing holdings. Its largest new stake was Tesla: 619,500 shares worth $218M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 8.5% of assets, up from 0.74% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Moderna, an estimated $9.79M trimmed.
- SG3 Management's largest Q4 2021 buy was Tesla: 619,500 shares worth $218M.
- SG3 Management added most to Amazon in Q4 2021, an estimated $165M increase.
- SG3 Management's biggest Q4 2021 reduction was Moderna, cutting an estimated $9.79M.
- SG3 Management fully exited Acceleron Pharma in Q4 2021, selling an estimated $10.3M.
- SG3 Management's ten largest holdings make up 37% of its $4.92B portfolio in Q4 2021.
- SG3 Management opened 468 new positions and closed 410 in Q4 2021.
- SG3 Management's portfolio value rose 49% quarter-over-quarter to $4.92B.
Based on SG3 Management's 13F filing for Q4 2021, filed 15 Feb 2022.